News & Articles

Healthcare Newsletter and Deal Tracker

Overview of M&A and Capital Raising in the UK Healthcare Sector

 

Welcome to the Winter edition of Adam Street’s Healthcare Newsletter and Deal Tracker.

 

As we reach the end of one of the most uncertain years in recent geopolitical history, things are starting to look a bit brighter than six months ago. For a start, Theresa May has secured overwhelming support from Parliament to trigger Article 50 in March 2017. Whilst not ideal for some, it at least gives British business a level of certainty regarding the process and timetable for leaving the European Union. Thankfully, none of the catastrophic economic events predicted by the Remain campaigners materialised. In the US, unsurprisingly, Trump is softening his stance on his pre-election rhetoric and even going as far as to suggest that the UK will have a free-trade deal with the US.

 

To be successful, businesses need to tune in and adapt to a changing environment.  At Adam Street, we remain highly optimistic that some sectors of the UK Healthcare market will continue to thrive, whereas others, particularly those exposed to high levels of government funding, will face challenges. On the whole, M&A activity in the UK Healthcare sector remains strong and we believe that it will continue to grow in 2017, despite valuation multiples in some government funded businesses declining.  

 

In this newsletter, Adam Street, has conducted a thorough review of M&A and investment activity within the UK Healthcare sector. A total of 103 significant transactions have taken place over the past 2 years. The majority of transactions were in the Elderly Care sector, with US investment funds being the most active acquirers.

 

Across the group, our team of professional advisers has many years’ experience advising both education and healthcare companies, their shareholders and management teams on selling and acquiring businesses, raising capital, refinancing and restructuring. Should you wish to discuss our views on the healthcare sector in more detail or explore options available to you and your business, we would be very interested in having a conversation with you.

 

We trust that the newsletter makes for interesting reading and should you wish to discuss some of the valuation multiples behind some of the transactions mentioned in our Newsletter, please do not hesitate to contact us. We look forward to hearing from you.

 

 

Please click here to download our newsletter and deal tracker.

Adam Street Advisers Corporate Finance LLP, a limited liability partnership in England and Wales (OC338478) and Adam Street Advisers Limited, a limited company registered in England and Wales (09579715) together trade as Adam Street Advisers. Adam Street Advisers Corporate Finance LLP is authorised and regulated by the Financial Conduct Authority (487620). Registered office: 21 Ganton Street, London, W1F 9BN.

© Adam Street Advisers 2020

Adam Street Advisers